New Systemic Standard for Anal Cancer?

(MedPage Today) -- A less toxic chemotherapy regimen for advanced anal cancer achieved at least similar disease control in a randomized comparison with a widely used standard-of-care regimen.
Carboplatin plus paclitaxel led to an objective response...